Detalhe da pesquisa
1.
Nivolumab Safety in Renal Cell Carcinoma: A Case Report.
J Pharm Technol
; 40(2): 112-117, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38525093
2.
Aducanumab for Alzheimer's disease: A regulatory perspective.
Pharmacol Res
; 171: 105754, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34217830
3.
Quality Issues Identified During the Evaluation of Biosimilars by the European Medicines Agency's Committee for Medicinal Products for Human Use.
AAPS PharmSciTech
; 19(2): 489-511, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29027130
4.
Changing paradigms in bioequivalence trials submitted to the EMA for evaluation - A clinical and regulatory perspective.
Saudi Pharm J
; 25(2): 280-289, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28344480
5.
Optimising bench science to withstand regulatory scrutiny.
Pharmacol Res
; 139: 491-493, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30321599
6.
An exploratory study of knowledge, attitudes, practice and barriers towards adverse drug reaction reporting among healthcare professionals in Malta.
Int J Risk Saf Med
; 2024 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38820023
7.
Alzheimer's disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?
Front Pharmacol
; 14: 1196413, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37332353
8.
The pharmacological treatment of granulomatosis with polyangiitis: a review of clinical trials registered in clinicaltrials.gov and the International Clinical Trials Registry Platform.
Ther Adv Rare Dis
; 4: 26330040231213888, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38116207
9.
An Exploratory Study of the Impact of COVID-19 Vaccine Spontaneous Reporting on Masking Signal Detection in EudraVigilance.
Drug Saf
; 46(11): 1089-1103, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37707778
10.
QT shortening: a proarrhythmic safety surrogate measure or an inappropriate indicator of it?
Curr Med Res Opin
; 38(9): 1473-1483, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35621140
11.
Improving the data quality of spontaneous ADR reports: a practical example from Malta.
Expert Opin Drug Saf
; 21(2): 253-268, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34649475
12.
Outcomes and endpoints in clinical trials supporting the marketing authorisation of treatments in paediatric acute lymphoblastic leukaemia.
Drug Discov Today
; 27(9): 2440-2466, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35597514
13.
The changing landscape of treatment options in childhood acute lymphoblastic leukaemia.
Drug Discov Today
; 27(5): 1483-1494, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35007767
14.
Regulatory experience of handling Risk Management Plans (RMPs) for medicinal products in the EU.
Expert Opin Drug Saf
; 20(7): 815-826, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33843379
15.
A Healthy Gut for a Healthy Brain: Preclinical, Clinical and Regulatory Aspects.
Curr Neuropharmacol
; 19(5): 610-628, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32744976
16.
Treatment of Leber's hereditary optic neuropathy: An overview of recent developments.
Eur J Ophthalmol
; 30(6): 1220-1227, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32552047
17.
Where is industry getting it wrong? A review of quality concerns raised at Day 120 by the Committee For Medicinal Products for Human Use during European Centralised Marketing Authorisation Submissions for Chemical Entity Medicinal Products.
J Pharm Pharm Sci
; 12(2): 181-98, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19732496
18.
Teaching pharmacy in Malta '1676 - 1990s' Part II.
Pharm Hist (Lond)
; 44(3): 68-73, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25335227
19.
Teaching pharmacy in Malta 1676-1990s: Part I.
Pharm Hist (Lond)
; 44(2): 24-6, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25029771
20.
Regulatory sciences and translational pharmacogenetics: amitriptyline as a case in point.
Drug Metab Pers Ther
; 34(2)2019 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31145691